2018
DOI: 10.1016/j.clbc.2018.06.015
|View full text |Cite
|
Sign up to set email alerts
|

Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
83
0
6

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 90 publications
(90 citation statements)
references
References 100 publications
1
83
0
6
Order By: Relevance
“…There is a paucity of data describing persistent PN in ESBC patients Xiao et al [ 50 ] 2018 Effects of adjuvant endocrine therapy on the QOL of post-menopausal women with non-metastatic ER+ Systematic review 3 13 Yes No Most studies found no differences between tamoxifen and aromatase inhibitor groups in terms of global QOL. The QOL of post-menopausal women is unlikely to be adversely affected by long-term use of adjuvant endocrine therapy Yee et al [ 51 ] 2018 Radiation-induced skin toxicity in breast cancer patients Systematic review NA 96 Yes No Methods including simultaneous integrated boost, accelerated partial breast irradiation, and prone positioning may cause less radiation dermatitis than conventional treatments Cheng et al [ 52 ] 2018 QOL of elderly patients with solid tumors undergoing adjuvant cancer therapy Systematic review 5 4 Yes Yes Adjuvant chemotherapy and radiotherapy may not have detrimental effects on QOL in most elderly patients with solid tumors Muller et al [ 53 ] 2018 Impact of manual lymphatic drainage on the HRQOL Systematic review 6 8 Yes Yes No studies reported reductions in HRQOL, or severe adverse events after MLD Jeffs et al [ 54 ] 2018 Effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema Systematic review 3 7 …”
Section: Resultsmentioning
confidence: 99%
“…There is a paucity of data describing persistent PN in ESBC patients Xiao et al [ 50 ] 2018 Effects of adjuvant endocrine therapy on the QOL of post-menopausal women with non-metastatic ER+ Systematic review 3 13 Yes No Most studies found no differences between tamoxifen and aromatase inhibitor groups in terms of global QOL. The QOL of post-menopausal women is unlikely to be adversely affected by long-term use of adjuvant endocrine therapy Yee et al [ 51 ] 2018 Radiation-induced skin toxicity in breast cancer patients Systematic review NA 96 Yes No Methods including simultaneous integrated boost, accelerated partial breast irradiation, and prone positioning may cause less radiation dermatitis than conventional treatments Cheng et al [ 52 ] 2018 QOL of elderly patients with solid tumors undergoing adjuvant cancer therapy Systematic review 5 4 Yes Yes Adjuvant chemotherapy and radiotherapy may not have detrimental effects on QOL in most elderly patients with solid tumors Muller et al [ 53 ] 2018 Impact of manual lymphatic drainage on the HRQOL Systematic review 6 8 Yes Yes No studies reported reductions in HRQOL, or severe adverse events after MLD Jeffs et al [ 54 ] 2018 Effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema Systematic review 3 7 …”
Section: Resultsmentioning
confidence: 99%
“…There are still no well-established prophylactic treatments available to prevent RT-induced skin toxicity. 26 We previously reported that prophylactic skincare significantly attenuated the risk of radiation dermatitis. 12 Greater than 90% of patients in the study received prophylactic skin treatment.…”
Section: Discussionmentioning
confidence: 98%
“…The acute radiation skin toxicity observed in the trial was comparable to that expected with standard RT alone, including in patients with cancer infiltrating overlying skin. 25 There were no cases of tumor lysis syndrome. Figure 2B (i) and Table E2 detail the tumor response based on US measurements at successive time points posttreatment.…”
Section: Primary Endpointmentioning
confidence: 97%